Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
KPC Pharmaceuticals Inc (KPC) is a pharmaceutical company that specializes in the development and production of natural medicine products. The company's main activities include drug research and development, production, sales, commercial wholesale, and international marketing. It offers products such as three series of Artemisia annua, Panax notoginseng, and Gastrodia elata, along with over forty new natural medicine products. The company serves its products under the brands Tianxuanqing, Luotai, Artemedine, Arco, and Artem. KPC’s drugs are used for the treatment of central nervous system disorders, cardiovascular, cardio-cerebral-vascular, chronic disease, disorders, and malaria. It has operations across Asia, Europe, Africa, Oceania, and South America. KPC is headquartered in Kunming, Yunnan, China.
KPC Pharmaceuticals Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Artemether | Artem |
| Gastrodia Elata | Arco |
| Panax Notoginseng | Luotai |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
Competitor Comparison
| Key Parameters | KPC Pharmaceuticals Inc | Jointown Pharmaceutical Group Co Ltd | Shenzhen Neptunus Bioengineering Co Ltd | Jiangsu Nhwa Pharmaceutical Co Ltd | Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd |
|---|---|---|---|---|---|
| Headquarters | China | China | China | China | China |
| City | Kunming | Wuhan | Shenzhen | Xuzhou | Hangzhou |
| State/Province | Yunnan | Hubei | Guangdong | Jiangsu | Zhejiang |
| No. of Employees | 5,072 | 29,862 | 6,734 | 6,003 | 392 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Wu Wenduo | Chairman | Executive Board | 2025 | 53 |
| Yan Wei | President; Vice Chairman | Executive Board | 2023 | 55 |
| Li Hongshen | Vice Chairman | Executive Board | 2024 | 48 |
| Gao Tong | Vice President | Senior Management | 2024 | 46 |
| Liu Junfeng | Senior Vice President | Senior Management | 2017 | 50 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer